Positron Corporation
6 News & Press Releases found

Positron Corporation news

The Frost & Sullivan Award for New Product Innovation Award is presented each year to the company that has demonstrated excellence in new products and technologies within its industry. The recipient company has shown innovation by launching a broad line of emerging products and technologies.

May. 22, 2022

Niagara Falls, NY – February 17, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging device systems and clinical services company, is pleased to announce today that the Company has retained Medical Device Academy ”MDA”) as its consultant for the Company’s new PET/CT device 510K submission with the Food and Drug Administration (“FDA”).

Positron will be applyin

Feb. 17, 2022

In consideration of our announcement of the collaboration with Neusoft Medical Systems and the expansion into the PET/CT modality we are pleased to update you on key developments that set the path for the growth and success at Positron for many years to come.

As many of our investors know, in 2021 Positron returned to being a full reporting company with the OTC Markets. The Company will continue filing quarterly and annual reports in a timely fashion. Our plan for 2022 is to matricula

Jan. 31, 2022

Positron Enters Long Term Cooperation Agreement with Neusoft Medical Systems for the Development and Distribution of Positron’s State of the Art PET/CT System in North America

Niagara Falls, NY – January 18, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging company specializing in the field of cardiac Positron Emission Tomography (“PET”) imaging systems and clinical se

Jan. 19, 2022

Positron Files all Financial Reports and Announces the Company is Current with its OTC Reporting & Disclosures

Niagara Falls, NY – October 29, 2021 (GLOBE NEWSWIRE) -- Positron Corp (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging company specializing in the field of cardiac Positron Emission Tomography (“PET”) imaging, is pleased to announce today that the Company is now fully reporting and “Current” w

Oct. 28, 2021